Chimerism of unseparated marrow nucleated cells
Posttransplantation evaluation . | No. patients per percentages of donor cells at evaluation . | . | . | . | No. nonevaluable patients† . | |||
|---|---|---|---|---|---|---|---|---|
| . | 100%* . | 90%-99% . | 50%-89% . | 0%-49% . | . | |||
| Day 30 | 71 | 8 | 6 | 6 | 19 | |||
| Day 100 | 47 | 9 | 4 | 2 | 48 | |||
| Day 180 | 44 | 3 | 2 | 1 | 60 | |||
| Year 1 | 32 | 1 | 1 | 0 | 76 | |||
| Year 2 | 13 | 0 | 0 | 1 | 96 | |||
| Year 3 | 4 | 0 | 0 | 0 | 106 | |||
Posttransplantation evaluation . | No. patients per percentages of donor cells at evaluation . | . | . | . | No. nonevaluable patients† . | |||
|---|---|---|---|---|---|---|---|---|
| . | 100%* . | 90%-99% . | 50%-89% . | 0%-49% . | . | |||
| Day 30 | 71 | 8 | 6 | 6 | 19 | |||
| Day 100 | 47 | 9 | 4 | 2 | 48 | |||
| Day 180 | 44 | 3 | 2 | 1 | 60 | |||
| Year 1 | 32 | 1 | 1 | 0 | 76 | |||
| Year 2 | 13 | 0 | 0 | 1 | 96 | |||
| Year 3 | 4 | 0 | 0 | 0 | 106 | |||